Background. Invasive candidiasis (IC) has a mortality of >30% and likelihood of death increases 50% each day antifungal therapy (AF) is delayed. In patients with suspected IC early empiric AF improves outcomes but has the potential for overuse. Blood cultures (BC) detect ~50% of candidemia with a turn-around-time (TAT) of 2-5 days. T2Candida Panel (T2) an FDA-approved molecular diagnostic test, detects 5 Candida species directly in blood with specificity 99.4%, sensitivity 91.1%, and TAT of 3-5 hours. Our institutional guidelines permit the use of empiric AF in patients with suspected IC (Figure 1) . We evaluated the utility of T2 as an AF stewardship tool to support these guidelines.
Methods. We reviewed patients that had T2 done January 2016 to May 2016 at Henry Ford Hospital, a 900-acute care bed teaching hospital in Detroit, MI. Patients with negative T2 [T2(−)] and negative concurrent BC [BC (−)] were evaluated. The primary endpoint was discontinuation (d/c) of AF after a T2 (−) result. Secondary endpoints were candidemia after d/c of AF and all-cause 30-day mortality. Comparative analyses were performed of transplant (txp) vs. non-transplant (non-txp) patients. Univariate analysis was done to determine the association of risk factors and outcomes. Multivariate regression using forward selection was used to model mortality risk. Time to d/c of AF were modeled using Kaplan-Meier estimators.
Results. 500 consecutive patients with T2 (−) and BC (−) results were identified. Patients on AF for prophylaxis or treatment of fungal infection were excluded. 472 patients (93 txp patients) were included in the analyses. Characteristics of the txp and non-txp patients are in Table 1 . Median TAT in hours (hr) of T2 was 6 (±2) vs. 123 (±25) for final BC (−) result. 264/472 (56%) patients were initiated on empiric AF. In patients with T2 (−) result, AF were d/c within 7 days in 97%; time to d/c of AF was 72 hr in 50% txp patients and 48 hr in 50% of non-txp patients respectively ( Figure 2 ). No episodes of candidemia were diagnosed after d/c of AF. All-cause mortality was lower in txp patients (14%) vs. non-txp patients (34%) (P = 0.0002). Likelihood of mortality did not increase after d/c of AF (OR1.3, 95% CI 0.913-2.064).
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Thirty-Day Mortality Among Patients with Candidemia Diagnosed by T2Candida Assay Alone: Influence of Risk Factors and Candida Species
Methods. We conducted a retrospective analysis of positive T2C cases at UAB Medical Center from 2016 to 2018 with either negative or no BC. For each patient we determined if clinical signs (e.g., hypotension, leukocytosis) and risk factors for candidemia were present at the time of collection. Our primary outcome of interest was 30-day mortality. Data were compared by multivariate analysis.
Results. A total of 173 patients with T2C positivity alone were included in the analysis. The most common risk factor was the use of broad-spectrum antibiotics followed by CVC (Table 1 ). The mean number of risk factors per patient was 3.6 ( Figure  1) . Overall 30-day mortality was 41%. Patients with a T2C result of C. albicans/C. tropicalis were almost 2.5 times more likely to die at 30 days (aOR 2.401, CI 1.159-4.974) compared with those with other positive results. Increasing number of risk factors (aOR 1.457, CI 1.126-1.886) and increasing age (aOR 1.052, CI 1.026-1.079) were significantly associated with increased odds of death at 30 days (Table 2) .
Conclusion. In this study we demonstrate a significant association between increasing number of risk factors, older age, and A/T result with higher odds of 30-day mortality among patients with T2C positivity alone. While concern for false-positives exists when using T2C, our data suggest that this is an acutely ill population which warrants early and aggressive antifungal therapy. The lower limit of detection of T2C (1 cfu/mL) as compared with BC may explain lack of paired positive cultures in these patients despite clinical signs of and risk factors for candidemia.
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Limited Diagnostic Utility of Extended Aerobic Blood Culture Incubation for Fungal Pathogen Detection
Lori Bourassa, PHD MPH 1 ; Olivia Kates, MD 1 and Catherine Liu, MD 2 ; 1 University of Washington, Seattle, Washington; 2 Fred Hutchinson Cancer Research Center, Seattle, Washington Session: 40. Fungal Diagnostics Thursday, October 3, 2019: 12:15 PM Background. Blood cultures are an important diagnostic tool for the detection of fungemia. At our institution, fungal blood cultures consist of aerobic blood culture with incubation extended from the standard 5 days to 14 days. Orders for fungal blood cultures exist in multiple electronic order sets for selected populations, including oncology and bone marrow transplant services.
Methods. To determine the yield of fungal blood cultures at our institution, a 570-bed tertiary-care referral center, we extracted all fungal blood culture results over a 4.5-year period (January 1, 2014-May 15, 2018) from a Laboratory Information System.
Results. Of the 21,657 fungal blood cultures performed, only 202 (0.9%) demonstrated growth and 189 (0.9%) grew fungal organisms. The majority (90%, n = 182/202) of positive fungal blood cultures grew a Candida or other yeast species. 96% (n = 174/182) of the fungal cultures that grew yeast would have been detected with standard bacterial blood culture. Eight of these cultures became positive during the extended hold period and grew a Candida species. All 8 cultures were collected from patients who had previous positive cultures for the same Candida species detected by standard incubation. Five fungal blood cultures from 4 patients turned positive after 5 days of incubation. Among these, two additional fungal pathogens were identified including 2 cases of Lomentospora prolificans and 2 cases of Fusarium. In both cases of L. prolificans and one case of Fusarium, the patients had previous positive blood cultures that detected the same organism with standard incubation. One patient with Fusarium had no previous positive blood cultures, but had multiple tissue cultures positive for Fusarium. The remaining cultures that turned positive after 5 days of incubation contained bacterial organisms, a number of which were considered clinically insignificant (e.g., Cutibacterium species).
Conclusion. These data suggest that extended incubation of aerobic blood culture bottles has limited diagnostic utility beyond standard bacterial blood culture for detection of fungemia. Fungal blood cultures represent an opportunity for improved diagnostic test stewardship, and use should be restricted to selected situations in consultation with Infectious Diseases or Laboratory Medicine.
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